Skip to content

Molecular markers for diagnosis and therapy response in Inflammatory Bowel diseases: A prospective population based bio-bank of inflammatory bowel disease patients in Zuid Limburg, The Netherlands.

Molecular markers for diagnosis and therapy response in Inflammatory Bowel diseases: A prospective population based bio-bank of inflammatory bowel disease patients in Zuid Limburg, The Netherlands. - A Prospective population based biobank for IBD in The Netherlands.

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON50587
Enrollment
5000
Registered
2011-03-02
Start date
2011-03-15
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

inflammatory bowel disease

Interventions

None listed

Sponsors

Interne geneeskunde/Divisie MDL
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inflammatory bowel disease patients of 18 years or older living in South-Limburg, The Netherlands. Patients should be competent to give consent. Partners living on the same address as the patient and parents of all the patients in the project., Addendum3, controls for GIS research question: Controls must be >18years, and their residence must be equally divided throughout South Limburg.

Exclusion criteria

Exclusion criteria: IBD patients not living in South Limburg Patients mentally incompetent Patients under the age of 18

Design outcomes

Primary

MeasureTime frame
niet van toepassing

Secondary

MeasureTime frame
niet van toepassing

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)